Hanseatic Life Science Research Infrastructure Consortium (HALRIC)

To promote research, innovation, and business development within the life science field, Medicon Village initiates, drives, and engages in initiatives and collaborations with partners, as prerequisites for growth and added value.

The HALRIC is an EU-supported initiative aimed at enhancing the utilization of robust and unique life science research infrastructures and competences within Northern Europe – specifically in Denmark, Southern Sweden, the Hamburg region, and the Oslo region. The primary goal of this initiative is to foster increased engagement between companies, hospitals, and large-scale research infrastructures (MAX IV, ESS, EuXFEL, and DESY), as well as smaller-scale infrastructures, by supporting up to 75 collaborative pilot projects. The consortium will also focus on developing prototype models to manage the substantial volume of electronic data generated by these highly specialized infrastructures. Additionally, the project aims to strengthen the life science ecosystems and foster strategic dialogues among the participating countries.

This project is scheduled from April 2023 to July 2026 and receives co-financing from the EU Interreg Öresund-Kattegat-Skagerrak program.

Project partners:

The project has 21 partner organisations across Sweden, Denmark, Germany and Norway, encompassing universities, hospitals, large-scale infrastructures, regional governments, and life science organisations:

• SWEDEN: Lund University, Malmö University, MAX IV, ESS, Skåne University Hospital, Region Skåne, Medicon Village.
• DENMARK: University of Copenhagen, Technical University of Denmark, Aarhus University, University of Southern Denmark, Rigshospitalet/Region Hovedstaden, Medicon Valley Alliance.
• GERMANY: University of Hamburg, EMBL, DESY, European XFEL, University Hospital Hamburg-Eppendorf, City of Hamburg, Life Science Nord.
• NORWAY: University of Oslo.